Thomas Hughes is leaving Zafgen, which he led for nine years, in order to take the top job at another biotech company.
The job change comes 10 months after Hughes resigned as CEO of Zafgen (NASDAQ: ZFGN) and took on a new role as the Boston company’s president and chief scientific officer. Zafgen announced Hughes’ resignation from that role Thursday after the market close. Soon afterward, Cambridge, MA-based Navitor Pharmaceuticals announced that Hughes has been appointed that company’s new CEO.
Hughes joined Zafgen in 2008, leaving a post at the Novartis Institutes for Biomedical Research to take the CEO… Read more »
UNDERWRITERS AND PARTNERS